Oct 07, 2020
Justin Zamirowski to lead upcoming launches of Better Therapeutics’ maturing prescription digital therapeutics product portfolio with a near term focus on type 2 diabetes and associated comorbidities. We recently  announced  the appointment of Justin Zamirowski as Chief Commercial Officer.
Oct 09, 2019
Today, we announced the publication of our  fifth peer-reviewed study  titled "Estimating the impact of novel digital therapeutics in type 2 diabetes and hypertension: Health economic analysis." Key findings were presented earlier this year at The International Society for Pharmacoeconomics and
Jul 24, 2019
Machine learning transformed data from using a digital therapeutic into digital biomarkers that predicted treatment response in individual participants. Today, we  announced  the  publication  of our latest study titled "Emergence of digital biomarkers to predict and modify treatment efficacy: a
Apr 03, 2019
With a highly regarded career designing products for startups, growth and enterprise companies, Kristin leads Better’s product design and branding functions as Head of Design. Kristin is a Silicon Valley native and a veteran of the tech industry since 1996.
Oct 23, 2018
Individuals with diabetes lowered A1c by an average of -.8%; further improvement was observed following the treatment period 91% of individuals with hypertension lowered blood pressure; systolic BP reduced by an average of -11.4 mmHg Today, at the annual meeting of the American College of Lifestyle
Feb 15, 2018
Results of our peer-reviewed clinical study published today in the  Journal of Medical Internet Research  demonstrate the potential for lifestyle therapy, delivered as a digital therapeutic, to become a widely-accessible and affordable solution for treating individuals with type II diabetes.
Displaying 31 - 40 of 41